- Yale-New Haven Children's Hospital-Pediatric Specialty CenterYale New Haven Hospital20 York Street, Wing West Pavilion 2 Fl 2ndNew Haven, CT 06510
- Yale Pediatric Specialty Center1 Long Wharf DriveSte 2nd FloorNew Haven, CT 06511
- Trumbull Pediatric Specialty Center5520 Park AvenueTrumbull, CT 06611
- YNHH Pediatric Specialty Center747 Belden AvenueNorwalk, CT 06850
Catherine Dinauer, MD
Biography
Catherine Dinauer, MD, is a pediatric endocrinologist who cares for patients from newborns to young adults. She specializes in pediatric thyroid disorders, including hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer, as well as general pediatric endocrinology disorders such as pituitary, adrenal, and growth problems.
“I love getting to know my patients and their families over time, and watching children with complicated disorders grow up and become healthy young adults,” says Dr. Dinauer. “Endocrinology involves helping children reach their full potential in the setting of chronic or underlying disease processes, and I enjoy the intellectual challenge involved in that. It’s like solving a puzzle, putting together symptoms, growth patterns, the physical exam, and lab and imaging findings to make a diagnosis.”
Dr. Dinauer says Yale offers children with endocrine disorders the best of all worlds, providing them with a multidisciplinary team that includes pediatric and endocrine surgeons, radiologists (with expertise in pediatrics, ultrasonography, and nuclear medicine), and pediatric and endocrine pathologists.
Before joining Yale Medicine, Dr. Dinauer was an attending physician at Walter Reed Army Medical Center in Washington, DC, and assistant chief of the department of clinical investigation at the Uniformed Services University of Health Sciences in Bethesda, MD. She was a co-author on the American Thyroid Association’s Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer, published in 2015.
Titles
- Associate Professor of Pediatrics (Endocrinology)
Education & Training
- FellowUniformed Services University of Health Sciences (1998)
- ResidentWalter Reed Army Medical Center (1994)
- MDUniversity of Vermont, College of Medicine (1991)
- ABDartmouth College, Psychology modified with Education (1987)
Additional Information
- General Graves B. Erskine Award for Outstanding Fellow: U.S. Army, Walter Reed Army Medical Center (1998)
- Fellow Clinical Research Award: American Pediatric Society/Society for Pediatric Research (1998)
- Army Commendation Medal: U.S. Army (1995), (1996), (1997), (1998)
- Army Achievement Medal: U.S. Army (1994), (1998)
- AB of Pediatrics, Pediatric Endocrinology (1999, recertified: 2017)
- Thyroid Cancer Survivors' Association (2020): Speaker, 23rd International Thyroid Cancer Survivors' Conference, "Transitions: Helping Young Survivors Understand and Begin to Manage Their Thyroid Cancer"
- American Thyroid Association (2020 - 2022): Co-Chair of the Program Committee for the ATA 90th Annual Meeting (Sept 30- Oct 3, 2021).
- American Academy of Pediatrics (2020): American Academy of Pediatrics Project ECHO (Extension for Community Healthcare Outcomes), Pediatric Endocrinology Pearls for Pediatricians, “Thyroid Function and Disorders”
- American Thyroid Association (2019 - Present): Member of Task Force on Revision of Pediatric Thyroid Nodule and Cancer Guidelines
- American Thyroid Association (2019 - 2020): Clinical Thyroidology - Submitted 4 reviews/commentaries per year on articles published in the realm of pediatric thyroidology
- American Thyroid Association (2019 - Present): Member, Guidelines & Statement Committee
- American Thyroid Association (2018 - 2019): Co-Chair, 2019 American Thyroid Association Pediatric Thyroid Forum Satellite Symposia
- American Thyroid Association (2017 - 2019): Member, ATA Annual Meeting Program Committee
- American Thyroid Association (2017 - 2018): Co-Chair, 2018 American Thyroid Association Pediatric Thyroid Forum Satellite Symposia
- American Thyroid Association (2016 - 2017): Chair, Membership Committee
- Deziel N, Wang R, Warren J, Dinauer C, Ogilvie J, Clark C, Zhong C, Wiemels J, Morimoto L, Metayer C, Ma X. Exposures to Artificial Light at Night and Ambient Fine Particulate Matter and Risk of Pediatric Papillary Thyroid Cancer. ISEE Conference Abstracts 2024, 2024 DOI: 10.1289/isee.2024.0720.
- Spaulding S, Maayah M, Dinauer C, Prasad M, Darbinyan A, Morotti R, Christison-Lagay E. Molecular Genetics Augment Cytopathologic Evaluation and Surgical Planning of Pediatric Thyroid Nodules. Journal Of Pediatric Surgery 2024, 59: 975-980. PMID: 38246817, DOI: 10.1016/j.jpedsurg.2024.01.001.
- Goldfarb M, Dinauer C. Differences in the management of thyroid nodules in children and adolescents as compared to adults. Current Opinion In Endocrinology Diabetes And Obesity 2022, 29: 466-473. PMID: 35777975, DOI: 10.1097/med.0000000000000754.
- Rodriguez L, Dinauer C, Francis G. Treatment of hypothyroidism in infants, children and adolescents. Trends In Endocrinology And Metabolism 2022, 33: 522-532. PMID: 35537910, DOI: 10.1016/j.tem.2022.04.007.
- Quintanilla-Dieck L, Khalatbari HK, Dinauer CA, Rastatter JC, Chelius DC, Katowitz WR, Shindo ML, Parisi MT, Kazahaya K. Management of Pediatric Graves Disease. JAMA Otolaryngology - Head & Neck Surgery 2021, 147: 1110-1118. PMID: 34647991, DOI: 10.1001/jamaoto.2021.2715.
- Dinauer C. A Comparison of the Differences Between Dutch and American Thyroid Association Guidelines for the Management of Pediatric Thyroid Cancer. Clinical Thyroidology 2020, 32: 525-528. DOI: 10.1089/ct.2020;32.525-528.
- Darbinyan A, Morotti R, Cai G, Prasad ML, Christison‐Lagay E, Dinauer C, Adeniran AJ. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology–histopathology correlation in 7 patients. Cancer Cytopathology 2020, 128: 746-756. PMID: 32897650, DOI: 10.1002/cncy.22329.
- Dinauer C. Total Thyroidectomy Remains Appropriate as Initial Treatment for Children with Papillary Thyroid Cancer That Frequently Harbors Occult Bilateral Disease. Clinical Thyroidology 2020, 32: 333-336. DOI: 10.1089/ct.2020;32.333-336.
- Christison-Lagay ER, Baertschiger RM, Dinauer C, Francis G, Malek M, Lautz T, Aldrink J, Grant C, Rhee D, Ehrlich P, Dasgupta R, Abdessalam S, Committee O. Pediatric differentiated thyroid carcinoma: An update from the APSA Cancer Committee. Journal Of Pediatric Surgery 2020, 55: 2273-2283. PMID: 32553450, DOI: 10.1016/j.jpedsurg.2020.05.003.
- Joseph K, Dinauer C. “A Real Pain in the Neck”. Clinical Thyroidology 2020, 32: 251-254. DOI: 10.1089/ct.2020;32.251-254.
- Gummadavelli A, Dinauer C, McGuone D, Vining EM, Erson-Omay EZ, Omay SB. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature. Journal Of Clinical Neuroscience 2020, 78: 420-422. PMID: 32336638, DOI: 10.1016/j.jocn.2020.04.103.
- Dinauer C. Postoperative Preablation TSH-Stimulated Thyroglobulin May Predict Outcome of Differentiated Thyroid Cancer in Children. Clinical Thyroidology 2020, 32: 131-134. DOI: 10.1089/ct.2020;32.131-134.
- Rubinstein JC, Herrick-Reynolds K, Dinauer C, Morotti R, Solomon D, Callender GG, Christison-Lagay ER. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice. Journal Of Surgical Research 2020, 249: 58-66. PMID: 31923715, DOI: 10.1016/j.jss.2019.12.002.
- Dinauer C. The Block-and-Replace Method May Have a Role in the Management of Pediatric Graves’ Disease. Clinical Thyroidology 2020, 32: 17-19. DOI: 10.1089/ct.2020;32.17-19.
- Dinauer C. Children with Autoimmune Thyroid Disease Are at Increased Risk for Autoimmune Gastritis. Clinical Thyroidology 2019, 31: 463-466. DOI: 10.1089/ct.2019;31.463-466.
- Dinauer C. The Hypothalamic–Pituitary–Thyroid Axis Matures Earlier in Girls than in Boys. Clinical Thyroidology 2019, 31: 365-367. DOI: 10.1089/ct.2019;31.365-367.
- Dinauer C. Complication Rates for Pediatric Thyroid Surgery Are Lower at Higher-Volume U.S. Hospitals. Clinical Thyroidology 2019, 31: 237-239. DOI: 10.1089/ct.2019;31.237-239.
- Dinauer C. Malignancy Rates in Cytologically Indeterminate Thyroid Nodules among Children Are Lower Than Previously Reported but Remain Higher Than in Adults. Clinical Thyroidology 2019, 31: 158-161. DOI: 10.1089/ct.2019;31.158-161.
- Dinauer C. The Value of Thyroid-Function Testing in the Pediatric Inpatient Setting Is Low. Clinical Thyroidology 2019, 31: 52-54. DOI: 10.1089/ct.2019;31.52-54.
- Rubinstein JC, Dinauer C, Herrick-Reynolds K, Morotti R, Callender GG, Christison-Lagay ER. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer. Journal Of Pediatric Surgery 2018, 54: 129-132. PMID: 30361076, DOI: 10.1016/j.jpedsurg.2018.10.010.
- Clement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, Alexander EK, Bardi E, Brignardello E, Constine LS, Dinauer CA, Drozd VM, Felicetti F, Frey E, Heinzel A, van den Heuvel-Eibrink MM, Huang SA, Links TP, Lorenz K, Mulder RL, Neggers SJ, van Dijkum E, Oeffinger KC, van Rijn RR, Rivkees SA, Ronckers CM, Schneider AB, Skinner R, Wasserman JD, Wynn T, Hudson MM, Nathan PC, van Santen HM. Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treatment Reviews 2017, 63: 28-39. PMID: 29202445, DOI: 10.1016/j.ctrv.2017.11.005.
- Rivkees S, Dinauer C. The Pediatric Thyroid Nodule and Papillary Thyroid Cancer Management. 2017, 199-216. DOI: 10.1007/978-3-319-43618-0_13.
- Hardee S, Prasad ML, Hui P, Dinauer CA, Morotti RA. Pathologic Characteristics, Natural History, and Prognostic Implications of BRAFV600E Mutation in Pediatric Papillary Thyroid Carcinoma. Pediatric And Developmental Pathology 2017, 20: 206-212. PMID: 28521635, DOI: 10.1177/1093526616689628.
- Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Cancer 2016, 122: 1097-1107. PMID: 26784937, DOI: 10.1002/cncr.29887.
- Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015, 25: 716-759. PMID: 25900731, PMCID: PMC4854274, DOI: 10.1089/thy.2014.0460.
- Abi-Raad R, Virk RK, Dinauer CA, Prasad A, Morotti RA, Breuer CK, Sosa JA, Udelsman R, Rivkees SA, Prasad ML. C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase Domain. Human Pathology 2015, 46: 1121-1128. PMID: 26033033, DOI: 10.1016/j.humpath.2015.04.011.
- Bauer A, Francis G, Waguespack S, Dinauer C. Differentiated thyroid cancer in children. 2013, 106-118. DOI: 10.2217/ebo.12.534.
- Differentiated thyroid cancer in childrenin Clinical Management of Thyroid Cancer, ed. Kakudo K and Liu Z, Future Medicine, London, UK, 2013, pp 106-118 (e-book).
- Rivkees SA, Mazzaferri EL, Verburg FA, Reiners C, Luster M, Breuer CK, Dinauer CA, Udelsman R. The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy. Endocrine Reviews 2011, 32: 798-826. PMID: 21880704, PMCID: PMC3591676, DOI: 10.1210/er.2011-0011.
- Rivkees SA, Stephenson K, Dinauer C. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children. International Journal Of Pediatric Endocrinology 2010, 2010: 176970. PMID: 20224800, PMCID: PMC2833412, DOI: 10.1155/2010/176970.
- Rivkees S, Stephenson K, Dinauer C. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children. International Journal Of Pediatric Endocrinology 2010, 2010: 176970. DOI: 10.1186/1687-9856-2010-176970.
- Rivkees S, Dinauer C. Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in Children. 2009, 942-955. DOI: 10.1016/b978-0-12-374135-6.00098-4.
- The Use of 131-Iodine in the Treatment of Graves Disease in Childrenin Comprehensive Handbook of Iodine: Nutritional, Endocrine, and Pathological Aspects, ed. Preedy VR, Burrow GN, and Watson RR, Elsevier Inc., Oxford, UK, 2009, pp 943-955.
- Dinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in children: diagnosis and management. Current Opinion In Oncology 2008, 20: 59-65. PMID: 18043257, DOI: 10.1097/cco.0b013e3282f30220.
- Dinauer C, Francis GL. Thyroid Cancer in Children. Endocrinology And Metabolism Clinics Of North America 2007, 36: 779-806. PMID: 17673128, DOI: 10.1016/j.ecl.2007.04.002.
- Rivkees SA, Dinauer C. An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine. The Journal Of Clinical Endocrinology & Metabolism 2007, 92: 797-800. PMID: 17341574, DOI: 10.1210/jc.2006-1239.
- Powers PA, Dinauer CA, Tuttle RM, Francis GL. The MACIS Score Predicts the Clinical Course of Papillary Thyroid Carcinoma in Children and Adolescents. Journal Of Pediatric Endocrinology And Metabolism 2004, 17: 339-344. PMID: 15112910, DOI: 10.1515/jpem.2004.17.3.339.
- Powers PA, Dinauer CA, Tuttle RM, Francis GL. Treatment of Recurrent Papillary Thyroid Carcinoma in Children and Adolescents. Journal Of Pediatric Endocrinology And Metabolism 2003, 16: 1033-1040. PMID: 14513881, DOI: 10.1515/jpem.2003.16.7.1033.
- Powers PA, Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Francis GL. Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and Adolescents. Journal Of Pediatric Endocrinology And Metabolism 2003, 16: 693-702. PMID: 12880118, DOI: 10.1515/jpem.2003.16.5.693.
- Patel A, Fenton C, Terrell R, Powers P, Dinauer C, Tuttle R, Francis G. Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents. Journal Of Endocrinological Investigation 2002, 25: 675-683. PMID: 12240898, DOI: 10.1007/bf03345100.
- Shah R, Banks K, Patel A, Dogra S, Terrell R, Powers PA, Fenton C, Dinauer CA, Tuttle RM, Francis GL. Intense Expression of the B7-2 Antigen Presentation Coactivator Is an Unfavorable Prognostic Indicator for Differentiated Thyroid Carcinoma of Children and Adolescents. The Journal Of Clinical Endocrinology & Metabolism 2002, 87: 4391-4397. PMID: 12213904, DOI: 10.1210/jc.2002-011262.
- Patel A, Straight A, Mann H, Duffy E, Fenton C, Dinauer C, Tuttle R, Francis G. Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents. Journal Of Endocrinological Investigation 2002, 25: 403-408. PMID: 12035934, DOI: 10.1007/bf03344028.
- Straight A, Patel A, Fenton C, Dinauer C, Tuttle R, Francis G. Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents. Journal Of Endocrinological Investigation 2002, 25: 302-308. PMID: 12030599, DOI: 10.1007/bf03344009.
- Gupta S, Patel A, Folstad A, Fenton C, Dinauer C, Tuttle R, Conran R, Francis G. Infiltration of Differentiated Thyroid Carcinoma by Proliferating Lymphocytes Is Associated with Improved Disease-Free Survival for Children and Young Adults1. The Journal Of Clinical Endocrinology & Metabolism 2001, 86: 1346-1354. PMID: 11238531, DOI: 10.1210/jcem.86.3.7310.
- Ramirez R, Hsu D, Patel A, Fenton C, Dinauer C, Tuttle R, Francis G. Over‐expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clinical Endocrinology 2000, 53: 635-644. PMID: 11106926, DOI: 10.1046/j.1365-2265.2000.01124.x.
- Fenton C, Patel A, Dinauer C, Robie D, Tuttle R, Francis G. The Expression of Vascular Endothelial Growth Factor and the Type 1 Vascular Endothelial Growth Factor Receptor Correlate with the Size of Papillary Thyroid Carcinoma in Children and Young Adults. Thyroid 2000, 10: 349-357. PMID: 10807064, DOI: 10.1089/thy.2000.10.349.
- Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults.Patel A, Fenton C, Ramirez R, Dinauer CA, Tuttle RM, Nikiforov YE, Gary FL. Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults. Frontiers In Bioscience-Landmark 2000, 5: a1-9. PMID: 10702379, DOI: 10.2741/patel.
- Dinauer C, Tuttle R, Robie D, McClellan D, Francis G. Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma. Journal Of Pediatric Surgery 1999, 34: 1799-1804. PMID: 10626858, DOI: 10.1016/s0022-3468(99)90316-0.
- Fenton C, Anderson J, Lukes Y, Dinauer C, Tuttle RM, Francis GL. Ras mutations are uncommon in sporadic thyroid cancer in children and young adults. Journal Of Endocrinological Investigation 1999, 22: 781-789. PMID: 10614528, DOI: 10.1007/bf03343644.
- Ramirez R, Fenton C, Patel A, Dinauer C, Tuttle R, Francis G. Over-Expression of c-MET Is Associated with Increased Recurrence in Childhood Thyroid Cancer. Pediatric Research 1999, 45: 96-96. DOI: 10.1203/00006450-199904020-00574.
- Fenton C, Lukes Y, Dinauer C, Tuttle R, Francis G. The ret/PTC Mutations are Common in Sporadic Papillary Thyroid Cancer in Children. Pediatric Research 1999, 45: 89-89. DOI: 10.1203/00006450-199904020-00529.
- Dinauer C, Tuttle M, Robie D, McClellan D, Svec R, Adair C, Francis G. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clinical Endocrinology 1998, 49: 619-628. PMID: 10197078, DOI: 10.1046/j.1365-2265.1998.00584.x.
- Robie DK, Dinauer CW, Tuttle RM, Ward DT, Parry R, McClellan D, Svec R, Adair C, Francis G. The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer. Journal Of Pediatric Surgery 1998, 33: 1134-8; discussion 1139-40. PMID: 9694109, DOI: 10.1016/s0022-3468(98)90546-2.
- Dinauer C, Tuttle R, Robie D, McClellan D, Francis G. Aggressive Surgical Therapy Improves Disease Free Survival in Children with Class 1 Papillary Thyroid Cancer † 499. Pediatric Research 1998, 43: 88-88. DOI: 10.1203/00006450-199804001-00520.
- Dinauer C, Tuttle R, Robie D, McClellan D, Francis G. The Extent of Disease at Diagnosis Predicts Response to Initial Therapy for Papillary Thyroid Cancer. † 498. Pediatric Research 1998, 43: 87-87. DOI: 10.1203/00006450-199804001-00519.
- Wiswell TE, Tencer HL, Welch CA, Chamberlain JL. Circumcision in children beyond the neonatal period. Pediatrics 1993, 92: 791-3. PMID: 8233738.
- Yale-New Haven Children's Hospital-Pediatric Specialty CenterYale New Haven Hospital20 York Street, Wing West Pavilion 2 Fl 2ndNew Haven, CT 06510
- Yale Pediatric Specialty Center1 Long Wharf DriveSte 2nd FloorNew Haven, CT 06511
- Trumbull Pediatric Specialty Center5520 Park AvenueTrumbull, CT 06611
- YNHH Pediatric Specialty Center747 Belden AvenueNorwalk, CT 06850
Biography
Catherine Dinauer, MD, is a pediatric endocrinologist who cares for patients from newborns to young adults. She specializes in pediatric thyroid disorders, including hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer, as well as general pediatric endocrinology disorders such as pituitary, adrenal, and growth problems.
“I love getting to know my patients and their families over time, and watching children with complicated disorders grow up and become healthy young adults,” says Dr. Dinauer. “Endocrinology involves helping children reach their full potential in the setting of chronic or underlying disease processes, and I enjoy the intellectual challenge involved in that. It’s like solving a puzzle, putting together symptoms, growth patterns, the physical exam, and lab and imaging findings to make a diagnosis.”
Dr. Dinauer says Yale offers children with endocrine disorders the best of all worlds, providing them with a multidisciplinary team that includes pediatric and endocrine surgeons, radiologists (with expertise in pediatrics, ultrasonography, and nuclear medicine), and pediatric and endocrine pathologists.
Before joining Yale Medicine, Dr. Dinauer was an attending physician at Walter Reed Army Medical Center in Washington, DC, and assistant chief of the department of clinical investigation at the Uniformed Services University of Health Sciences in Bethesda, MD. She was a co-author on the American Thyroid Association’s Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer, published in 2015.
Titles
- Associate Professor of Pediatrics (Endocrinology)
Education & Training
- FellowUniformed Services University of Health Sciences (1998)
- ResidentWalter Reed Army Medical Center (1994)
- MDUniversity of Vermont, College of Medicine (1991)
- ABDartmouth College, Psychology modified with Education (1987)
Additional Information
- General Graves B. Erskine Award for Outstanding Fellow: U.S. Army, Walter Reed Army Medical Center (1998)
- Fellow Clinical Research Award: American Pediatric Society/Society for Pediatric Research (1998)
- Army Commendation Medal: U.S. Army (1995), (1996), (1997), (1998)
- Army Achievement Medal: U.S. Army (1994), (1998)
- AB of Pediatrics, Pediatric Endocrinology (1999, recertified: 2017)
- Thyroid Cancer Survivors' Association (2020): Speaker, 23rd International Thyroid Cancer Survivors' Conference, "Transitions: Helping Young Survivors Understand and Begin to Manage Their Thyroid Cancer"
- American Thyroid Association (2020 - 2022): Co-Chair of the Program Committee for the ATA 90th Annual Meeting (Sept 30- Oct 3, 2021).
- American Academy of Pediatrics (2020): American Academy of Pediatrics Project ECHO (Extension for Community Healthcare Outcomes), Pediatric Endocrinology Pearls for Pediatricians, “Thyroid Function and Disorders”
- American Thyroid Association (2019 - Present): Member of Task Force on Revision of Pediatric Thyroid Nodule and Cancer Guidelines
- American Thyroid Association (2019 - 2020): Clinical Thyroidology - Submitted 4 reviews/commentaries per year on articles published in the realm of pediatric thyroidology
- American Thyroid Association (2019 - Present): Member, Guidelines & Statement Committee
- American Thyroid Association (2018 - 2019): Co-Chair, 2019 American Thyroid Association Pediatric Thyroid Forum Satellite Symposia
- American Thyroid Association (2017 - 2019): Member, ATA Annual Meeting Program Committee
- American Thyroid Association (2017 - 2018): Co-Chair, 2018 American Thyroid Association Pediatric Thyroid Forum Satellite Symposia
- American Thyroid Association (2016 - 2017): Chair, Membership Committee
- Deziel N, Wang R, Warren J, Dinauer C, Ogilvie J, Clark C, Zhong C, Wiemels J, Morimoto L, Metayer C, Ma X. Exposures to Artificial Light at Night and Ambient Fine Particulate Matter and Risk of Pediatric Papillary Thyroid Cancer. ISEE Conference Abstracts 2024, 2024 DOI: 10.1289/isee.2024.0720.
- Spaulding S, Maayah M, Dinauer C, Prasad M, Darbinyan A, Morotti R, Christison-Lagay E. Molecular Genetics Augment Cytopathologic Evaluation and Surgical Planning of Pediatric Thyroid Nodules. Journal Of Pediatric Surgery 2024, 59: 975-980. PMID: 38246817, DOI: 10.1016/j.jpedsurg.2024.01.001.
- Goldfarb M, Dinauer C. Differences in the management of thyroid nodules in children and adolescents as compared to adults. Current Opinion In Endocrinology Diabetes And Obesity 2022, 29: 466-473. PMID: 35777975, DOI: 10.1097/med.0000000000000754.
- Rodriguez L, Dinauer C, Francis G. Treatment of hypothyroidism in infants, children and adolescents. Trends In Endocrinology And Metabolism 2022, 33: 522-532. PMID: 35537910, DOI: 10.1016/j.tem.2022.04.007.
- Quintanilla-Dieck L, Khalatbari HK, Dinauer CA, Rastatter JC, Chelius DC, Katowitz WR, Shindo ML, Parisi MT, Kazahaya K. Management of Pediatric Graves Disease. JAMA Otolaryngology - Head & Neck Surgery 2021, 147: 1110-1118. PMID: 34647991, DOI: 10.1001/jamaoto.2021.2715.
- Dinauer C. A Comparison of the Differences Between Dutch and American Thyroid Association Guidelines for the Management of Pediatric Thyroid Cancer. Clinical Thyroidology 2020, 32: 525-528. DOI: 10.1089/ct.2020;32.525-528.
- Darbinyan A, Morotti R, Cai G, Prasad ML, Christison‐Lagay E, Dinauer C, Adeniran AJ. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology–histopathology correlation in 7 patients. Cancer Cytopathology 2020, 128: 746-756. PMID: 32897650, DOI: 10.1002/cncy.22329.
- Dinauer C. Total Thyroidectomy Remains Appropriate as Initial Treatment for Children with Papillary Thyroid Cancer That Frequently Harbors Occult Bilateral Disease. Clinical Thyroidology 2020, 32: 333-336. DOI: 10.1089/ct.2020;32.333-336.
- Christison-Lagay ER, Baertschiger RM, Dinauer C, Francis G, Malek M, Lautz T, Aldrink J, Grant C, Rhee D, Ehrlich P, Dasgupta R, Abdessalam S, Committee O. Pediatric differentiated thyroid carcinoma: An update from the APSA Cancer Committee. Journal Of Pediatric Surgery 2020, 55: 2273-2283. PMID: 32553450, DOI: 10.1016/j.jpedsurg.2020.05.003.
- Joseph K, Dinauer C. “A Real Pain in the Neck”. Clinical Thyroidology 2020, 32: 251-254. DOI: 10.1089/ct.2020;32.251-254.
- Gummadavelli A, Dinauer C, McGuone D, Vining EM, Erson-Omay EZ, Omay SB. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature. Journal Of Clinical Neuroscience 2020, 78: 420-422. PMID: 32336638, DOI: 10.1016/j.jocn.2020.04.103.
- Dinauer C. Postoperative Preablation TSH-Stimulated Thyroglobulin May Predict Outcome of Differentiated Thyroid Cancer in Children. Clinical Thyroidology 2020, 32: 131-134. DOI: 10.1089/ct.2020;32.131-134.
- Rubinstein JC, Herrick-Reynolds K, Dinauer C, Morotti R, Solomon D, Callender GG, Christison-Lagay ER. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice. Journal Of Surgical Research 2020, 249: 58-66. PMID: 31923715, DOI: 10.1016/j.jss.2019.12.002.
- Dinauer C. The Block-and-Replace Method May Have a Role in the Management of Pediatric Graves’ Disease. Clinical Thyroidology 2020, 32: 17-19. DOI: 10.1089/ct.2020;32.17-19.
- Dinauer C. Children with Autoimmune Thyroid Disease Are at Increased Risk for Autoimmune Gastritis. Clinical Thyroidology 2019, 31: 463-466. DOI: 10.1089/ct.2019;31.463-466.
- Dinauer C. The Hypothalamic–Pituitary–Thyroid Axis Matures Earlier in Girls than in Boys. Clinical Thyroidology 2019, 31: 365-367. DOI: 10.1089/ct.2019;31.365-367.
- Dinauer C. Complication Rates for Pediatric Thyroid Surgery Are Lower at Higher-Volume U.S. Hospitals. Clinical Thyroidology 2019, 31: 237-239. DOI: 10.1089/ct.2019;31.237-239.
- Dinauer C. Malignancy Rates in Cytologically Indeterminate Thyroid Nodules among Children Are Lower Than Previously Reported but Remain Higher Than in Adults. Clinical Thyroidology 2019, 31: 158-161. DOI: 10.1089/ct.2019;31.158-161.
- Dinauer C. The Value of Thyroid-Function Testing in the Pediatric Inpatient Setting Is Low. Clinical Thyroidology 2019, 31: 52-54. DOI: 10.1089/ct.2019;31.52-54.
- Rubinstein JC, Dinauer C, Herrick-Reynolds K, Morotti R, Callender GG, Christison-Lagay ER. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer. Journal Of Pediatric Surgery 2018, 54: 129-132. PMID: 30361076, DOI: 10.1016/j.jpedsurg.2018.10.010.
- Clement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, Alexander EK, Bardi E, Brignardello E, Constine LS, Dinauer CA, Drozd VM, Felicetti F, Frey E, Heinzel A, van den Heuvel-Eibrink MM, Huang SA, Links TP, Lorenz K, Mulder RL, Neggers SJ, van Dijkum E, Oeffinger KC, van Rijn RR, Rivkees SA, Ronckers CM, Schneider AB, Skinner R, Wasserman JD, Wynn T, Hudson MM, Nathan PC, van Santen HM. Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treatment Reviews 2017, 63: 28-39. PMID: 29202445, DOI: 10.1016/j.ctrv.2017.11.005.
- Rivkees S, Dinauer C. The Pediatric Thyroid Nodule and Papillary Thyroid Cancer Management. 2017, 199-216. DOI: 10.1007/978-3-319-43618-0_13.
- Hardee S, Prasad ML, Hui P, Dinauer CA, Morotti RA. Pathologic Characteristics, Natural History, and Prognostic Implications of BRAFV600E Mutation in Pediatric Papillary Thyroid Carcinoma. Pediatric And Developmental Pathology 2017, 20: 206-212. PMID: 28521635, DOI: 10.1177/1093526616689628.
- Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Cancer 2016, 122: 1097-1107. PMID: 26784937, DOI: 10.1002/cncr.29887.
- Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015, 25: 716-759. PMID: 25900731, PMCID: PMC4854274, DOI: 10.1089/thy.2014.0460.
- Abi-Raad R, Virk RK, Dinauer CA, Prasad A, Morotti RA, Breuer CK, Sosa JA, Udelsman R, Rivkees SA, Prasad ML. C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase Domain. Human Pathology 2015, 46: 1121-1128. PMID: 26033033, DOI: 10.1016/j.humpath.2015.04.011.
- Bauer A, Francis G, Waguespack S, Dinauer C. Differentiated thyroid cancer in children. 2013, 106-118. DOI: 10.2217/ebo.12.534.
- Differentiated thyroid cancer in childrenin Clinical Management of Thyroid Cancer, ed. Kakudo K and Liu Z, Future Medicine, London, UK, 2013, pp 106-118 (e-book).
- Rivkees SA, Mazzaferri EL, Verburg FA, Reiners C, Luster M, Breuer CK, Dinauer CA, Udelsman R. The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy. Endocrine Reviews 2011, 32: 798-826. PMID: 21880704, PMCID: PMC3591676, DOI: 10.1210/er.2011-0011.
- Rivkees SA, Stephenson K, Dinauer C. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children. International Journal Of Pediatric Endocrinology 2010, 2010: 176970. PMID: 20224800, PMCID: PMC2833412, DOI: 10.1155/2010/176970.
- Rivkees S, Stephenson K, Dinauer C. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children. International Journal Of Pediatric Endocrinology 2010, 2010: 176970. DOI: 10.1186/1687-9856-2010-176970.
- Rivkees S, Dinauer C. Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in Children. 2009, 942-955. DOI: 10.1016/b978-0-12-374135-6.00098-4.
- The Use of 131-Iodine in the Treatment of Graves Disease in Childrenin Comprehensive Handbook of Iodine: Nutritional, Endocrine, and Pathological Aspects, ed. Preedy VR, Burrow GN, and Watson RR, Elsevier Inc., Oxford, UK, 2009, pp 943-955.
- Dinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in children: diagnosis and management. Current Opinion In Oncology 2008, 20: 59-65. PMID: 18043257, DOI: 10.1097/cco.0b013e3282f30220.
- Dinauer C, Francis GL. Thyroid Cancer in Children. Endocrinology And Metabolism Clinics Of North America 2007, 36: 779-806. PMID: 17673128, DOI: 10.1016/j.ecl.2007.04.002.
- Rivkees SA, Dinauer C. An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine. The Journal Of Clinical Endocrinology & Metabolism 2007, 92: 797-800. PMID: 17341574, DOI: 10.1210/jc.2006-1239.
- Powers PA, Dinauer CA, Tuttle RM, Francis GL. The MACIS Score Predicts the Clinical Course of Papillary Thyroid Carcinoma in Children and Adolescents. Journal Of Pediatric Endocrinology And Metabolism 2004, 17: 339-344. PMID: 15112910, DOI: 10.1515/jpem.2004.17.3.339.
- Powers PA, Dinauer CA, Tuttle RM, Francis GL. Treatment of Recurrent Papillary Thyroid Carcinoma in Children and Adolescents. Journal Of Pediatric Endocrinology And Metabolism 2003, 16: 1033-1040. PMID: 14513881, DOI: 10.1515/jpem.2003.16.7.1033.
- Powers PA, Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Francis GL. Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and Adolescents. Journal Of Pediatric Endocrinology And Metabolism 2003, 16: 693-702. PMID: 12880118, DOI: 10.1515/jpem.2003.16.5.693.
- Patel A, Fenton C, Terrell R, Powers P, Dinauer C, Tuttle R, Francis G. Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents. Journal Of Endocrinological Investigation 2002, 25: 675-683. PMID: 12240898, DOI: 10.1007/bf03345100.
- Shah R, Banks K, Patel A, Dogra S, Terrell R, Powers PA, Fenton C, Dinauer CA, Tuttle RM, Francis GL. Intense Expression of the B7-2 Antigen Presentation Coactivator Is an Unfavorable Prognostic Indicator for Differentiated Thyroid Carcinoma of Children and Adolescents. The Journal Of Clinical Endocrinology & Metabolism 2002, 87: 4391-4397. PMID: 12213904, DOI: 10.1210/jc.2002-011262.
- Patel A, Straight A, Mann H, Duffy E, Fenton C, Dinauer C, Tuttle R, Francis G. Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents. Journal Of Endocrinological Investigation 2002, 25: 403-408. PMID: 12035934, DOI: 10.1007/bf03344028.
- Straight A, Patel A, Fenton C, Dinauer C, Tuttle R, Francis G. Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents. Journal Of Endocrinological Investigation 2002, 25: 302-308. PMID: 12030599, DOI: 10.1007/bf03344009.
- Gupta S, Patel A, Folstad A, Fenton C, Dinauer C, Tuttle R, Conran R, Francis G. Infiltration of Differentiated Thyroid Carcinoma by Proliferating Lymphocytes Is Associated with Improved Disease-Free Survival for Children and Young Adults1. The Journal Of Clinical Endocrinology & Metabolism 2001, 86: 1346-1354. PMID: 11238531, DOI: 10.1210/jcem.86.3.7310.
- Ramirez R, Hsu D, Patel A, Fenton C, Dinauer C, Tuttle R, Francis G. Over‐expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clinical Endocrinology 2000, 53: 635-644. PMID: 11106926, DOI: 10.1046/j.1365-2265.2000.01124.x.
- Fenton C, Patel A, Dinauer C, Robie D, Tuttle R, Francis G. The Expression of Vascular Endothelial Growth Factor and the Type 1 Vascular Endothelial Growth Factor Receptor Correlate with the Size of Papillary Thyroid Carcinoma in Children and Young Adults. Thyroid 2000, 10: 349-357. PMID: 10807064, DOI: 10.1089/thy.2000.10.349.
- Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults.Patel A, Fenton C, Ramirez R, Dinauer CA, Tuttle RM, Nikiforov YE, Gary FL. Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults. Frontiers In Bioscience-Landmark 2000, 5: a1-9. PMID: 10702379, DOI: 10.2741/patel.
- Dinauer C, Tuttle R, Robie D, McClellan D, Francis G. Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma. Journal Of Pediatric Surgery 1999, 34: 1799-1804. PMID: 10626858, DOI: 10.1016/s0022-3468(99)90316-0.
- Fenton C, Anderson J, Lukes Y, Dinauer C, Tuttle RM, Francis GL. Ras mutations are uncommon in sporadic thyroid cancer in children and young adults. Journal Of Endocrinological Investigation 1999, 22: 781-789. PMID: 10614528, DOI: 10.1007/bf03343644.
- Ramirez R, Fenton C, Patel A, Dinauer C, Tuttle R, Francis G. Over-Expression of c-MET Is Associated with Increased Recurrence in Childhood Thyroid Cancer. Pediatric Research 1999, 45: 96-96. DOI: 10.1203/00006450-199904020-00574.
- Fenton C, Lukes Y, Dinauer C, Tuttle R, Francis G. The ret/PTC Mutations are Common in Sporadic Papillary Thyroid Cancer in Children. Pediatric Research 1999, 45: 89-89. DOI: 10.1203/00006450-199904020-00529.
- Dinauer C, Tuttle M, Robie D, McClellan D, Svec R, Adair C, Francis G. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clinical Endocrinology 1998, 49: 619-628. PMID: 10197078, DOI: 10.1046/j.1365-2265.1998.00584.x.
- Robie DK, Dinauer CW, Tuttle RM, Ward DT, Parry R, McClellan D, Svec R, Adair C, Francis G. The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer. Journal Of Pediatric Surgery 1998, 33: 1134-8; discussion 1139-40. PMID: 9694109, DOI: 10.1016/s0022-3468(98)90546-2.
- Dinauer C, Tuttle R, Robie D, McClellan D, Francis G. Aggressive Surgical Therapy Improves Disease Free Survival in Children with Class 1 Papillary Thyroid Cancer † 499. Pediatric Research 1998, 43: 88-88. DOI: 10.1203/00006450-199804001-00520.
- Dinauer C, Tuttle R, Robie D, McClellan D, Francis G. The Extent of Disease at Diagnosis Predicts Response to Initial Therapy for Papillary Thyroid Cancer. † 498. Pediatric Research 1998, 43: 87-87. DOI: 10.1203/00006450-199804001-00519.
- Wiswell TE, Tencer HL, Welch CA, Chamberlain JL. Circumcision in children beyond the neonatal period. Pediatrics 1993, 92: 791-3. PMID: 8233738.
- Yale-New Haven Children's Hospital-Pediatric Specialty CenterYale New Haven Hospital20 York Street, Wing West Pavilion 2 Fl 2ndNew Haven, CT 06510
- Yale Pediatric Specialty Center1 Long Wharf DriveSte 2nd FloorNew Haven, CT 06511
- Trumbull Pediatric Specialty Center5520 Park AvenueTrumbull, CT 06611
- YNHH Pediatric Specialty Center747 Belden AvenueNorwalk, CT 06850
- Yale-New Haven Children's Hospital-Pediatric Specialty CenterYale New Haven Hospital20 York Street, Wing West Pavilion 2 Fl 2ndNew Haven, CT 06510
- Yale Pediatric Specialty Center1 Long Wharf DriveSte 2nd FloorNew Haven, CT 06511
- Trumbull Pediatric Specialty Center5520 Park AvenueTrumbull, CT 06611
- YNHH Pediatric Specialty Center747 Belden AvenueNorwalk, CT 06850